Showing results (51-60 of 212) with videos related to
Sort By:
Pageof 22
The Lancet. Haematology|September 23, 2024
Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantationTamim Alsuliman, Lugien Alasadi, Alice Polomeni, et al.Blood|December 15, 2005
Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantationHermann Einsele, Pierre Reusser, Martin Bornhäuser, et al.Open Forum Infectious Diseases|May 1, 2023
CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant RecipientsLara Chavaz, Léna Royston, Stavroula Masouridi-Levrat, et al.Frontiers in Medicine|October 12, 2017
TAFRO Syndrome in Caucasians: A Case Report and Review of the LiteratureCéline Louis, Sandrine Vijgen, Kaveh Samii, et al.Transplantation|May 16, 2006
Association of TNFd and IL-10 polymorphisms with mortality in unrelated hematopoietic stem cell transplantationFlorence Bettens, Jakob Passweg, Alois Gratwohl, et al.Antimicrobial Agents and Chemotherapy|March 30, 2021
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with LetermovirJean Terrier, Marie-Céline Zanella, Stavroula Masouridi-Levrat, et al.Leukemia|November 28, 2019
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantationStéphane Buhler, Florence Bettens, Carole Dantin, et al.Clinical Nuclear Medicine|September 8, 2012
Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better toleranceFranz Buchegger, John O Prior, Gilles Allenbach, et al.European Journal of Haematology|May 4, 2011
Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantationSabine Bieri, Eddy Roosnek, Hulya Ozsahin, et al.Swiss Medical Weekly|May 15, 2024
Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugsDominik Heim, Helen Baldomero, Michael Medinger, et al.Pageof 22